Minoru Nakamura Selected Research

anticentromere antibody

10/2011	Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.
1/2011	Risk factors and prediction of long-term outcome in primary biliary cirrhosis.
5/2010	Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC.
1/2007	Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minoru Nakamura Research Topics

Disease

34	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 05/2020 - 05/2003
10	Inflammation (Inflammations) 08/2019 - 04/2006
10	Liver Failure 01/2015 - 03/2005
9	Autoimmune Hepatitis 01/2020 - 07/2007
9	Fibrosis (Cirrhosis) 01/2019 - 04/2006
8	Liver Diseases (Liver Disease) 08/2019 - 01/2005
8	Jaundice (Icterus) 01/2018 - 01/2007
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2006
7	Hepatitis 12/2018 - 04/2006
7	Disease Progression 01/2018 - 01/2007
5	Infections 01/2016 - 01/2006
5	Portal Hypertension 09/2014 - 01/2007
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 01/2003
4	Rheumatoid Arthritis 11/2011 - 11/2006
3	Parkinson Disease (Parkinson's Disease) 10/2022 - 01/2013
3	Chronic Hepatitis C 01/2020 - 07/2007
3	Hepatitis B 03/2016 - 03/2007
3	Cholangitis 10/2013 - 04/2010
3	Neoplasms (Cancer) 01/2006 - 12/2003
2	Diarrhea 01/2020 - 07/2004
2	Chronic Hepatitis B 03/2016 - 12/2012
1	Gaucher Disease (Gaucher's Disease) 10/2022
1	Necrosis 05/2022
1	Disease Susceptibility (Diathesis) 05/2020
1	Dementia (Dementias) 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Alagille Syndrome (Alagille-Watson Syndrome) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2018
1	Disease Resistance 11/2017
1	Leprosy (Hansen's Disease) 10/2016
1	Communicable Diseases (Infectious Diseases) 10/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Hepatitis C 01/2016

Drug/Important Bio-Agent (IBA)

13	AntibodiesIBA 05/2022 - 03/2005
7	AutoantibodiesIBA 08/2015 - 01/2003
6	Alanine Transaminase (SGPT)IBA 08/2019 - 01/2011
6	CytokinesIBA 12/2018 - 01/2006
5	BilirubinIBA 08/2019 - 01/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 05/2011
4	anticentromere antibodyIBA 10/2011 - 01/2007
4	AutoantigensIBA 09/2008 - 01/2003
3	Carrier Proteins (Binding Protein)IBA 01/2020 - 12/2018
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 11/2006
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2005
3	Antinuclear AntibodiesIBA 05/2010 - 01/2007
3	Peptides (Polypeptides)IBA 10/2007 - 03/2005
2	Messenger RNA (mRNA)IBA 05/2020 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2019
2	ChemokinesIBA 08/2019 - 12/2018
2	Cathepsin ZIBA 01/2018 - 01/2018
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2018 - 09/2014
2	Immunoglobulin M (IgM)IBA 01/2017 - 08/2015
2	Bile Acids and Salts (Bile Acids)IBA 12/2016 - 10/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2016 - 12/2012
2	InterferonsIBA 01/2016 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 04/2006
2	LigandsIBA 05/2014 - 02/2010
2	ImmunosorbentsIBA 10/2013 - 07/2007
2	EnzymesIBA 10/2013 - 07/2007
2	Janus KinasesIBA 11/2011 - 05/2011
2	AlbuminsIBA 01/2011 - 10/2005
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2009 - 03/2008
2	Interleukin-6 (Interleukin 6)IBA 03/2008 - 01/2006
2	EpitopesIBA 11/2006 - 06/2005
2	Oxidoreductases (Dehydrogenase)IBA 03/2006 - 11/2003
2	Glycoproteins (Glycoprotein)IBA 03/2005 - 04/2001
2	Bacterial AntigensIBA 06/2003 - 05/2003
1	ceramide glucosyltransferaseIBA 10/2022
1	CD40 Ligand (CD40L)IBA 05/2020
1	Interferon-gamma (Interferon, gamma)IBA 05/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Mucin-3IBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	SynucleinsIBA 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	KynurenineIBA 01/2020
1	NucleotidesIBA 01/2019
1	SteroidsIBA 12/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	BezafibrateIBA 01/2018
1	negative elongation factorIBA 01/2018
1	HLA-DQ Antigens (HLA-DQ)IBA 11/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	asunaprevirIBA 01/2016
1	ledipasvirIBA 01/2016
1	SofosbuvirIBA 01/2016
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	HLA-A Antigens (HLA-A)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	daclatasvirIBA 01/2016
1	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 01/2016
1	Amyloid beta-PeptidesIBA 01/2016
1	oxidized low density lipoproteinIBA 01/2016

Therapy/Procedure

7	Therapeutics 12/2018 - 03/2003
5	Liver Transplantation 09/2014 - 01/2007